Experts: Journavx a prescription to stem Long Island's addiction crisis
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
Dr. Roach: A withdrawn drug is the only medication that works for reader
What happened to Darvon? It wasn’t addicting and didn’t cost much, and I never heard any reason why it was withdrawn except that “it didn’t work.” It sure ...
Newly approved painkiller Journavx is 'potentially groundbreaking'
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Cherokee Phoenix3d
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
Virginia Attorney General announces $7.4 billion settlement from Oxycontin maker for "fueling" opioid crisis
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
Virginia AG announces $7.4 billion settlement from Oxycontin maker for "fueling" opioid crisis
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...